Intelreason 03 of 4it makes it for less than anyone else canderived 2026-09-11accession 0000050863-26-000157
The restructuring actions are producing measurable operating-leverage: opex as a share of revenue dropped ~9 percentage points, and management states these cuts are structural. If revenue stabilizes or grows, the leaner cost base should translate into sharply higher operating margins, improving free-cash-flow generation.
the thesis · admitted · the reason above is the thesis, not printed twice
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedfive sentences · whole, uncut
the claims it rests on
Total R&D and MG&A expenses for Q2 2026 were $4.5 billion, down 6% from Q2 2025; these expenses represent 28.2% of revenue for Q2 2026 versus 37.5% for Q2 2025
R&D expenses decreased by $316 million, or 9%, from Q2 2025, primarily driven by lower payroll-related expenditures resulting from headcount reductions taken under the 2025 Restructuring Plan
As a result of our 2025 and 2024 Restructuring Plans and related cost-reduction measures, we expect total R&D and MG&A expenses to decrease in 2026 relative to recent historical periods
what it was checked against
structural opex cuts from restructuring
Operating income also benefited from $258 million of lower operating expenses, primarily related to lower payroll-related expenditures resulting from headcount reductions taken under the 2025 Restructuring Plan and the effects of various cost-reduction measures.
YTD opex reduction from restructuring
Operating income also benefited from $507 million of lower operating expenses, primarily related to lower payroll-related expenditures resulting from headcount reductions taken under the 2025 Restructuring Plan and the effects of various cost-reduction measures.